Archemin

Advice & reporting for the chemical and pharmaceutical industries

News & updates

Price-Volume Contracts for Expensive Medicines

posted on March 28th 2011 by Inneke Van de Vijver
In Belgium pharmaceutical companies can in some instances agree with the authorities on price-volume contracts where "normal" reimbursement is unlikely. A price-volume contract aims at controlling the budget of expensive medicinal products, even at increasing volumes.

Growing Team

posted on November 03rd 2010 by Ludwig Everaert
Pack Insert Readability Testing is picking up speed as predicted. We are in constant need of extra hands. In 2010 our team has already expanded by 30% and we are still hiring ...

New Offices

posted on June 28th 2010 by Ludwig Everaert
From July 1st, 2010 onwards, our new business address is Lange Nieuwstraat 1 - 2800 Mechelen (Belgium).

Class I Reimbursement

posted on April 15th 2010 by Inneke Van de Vijver
Hexvix has successfully passed its individual revision of Class I reimbursement.

Medicines Price revision in Morocco

posted on December 02nd 2009 by Inneke Van de Vijver
The prices of medicines in Morocco are fixed by the health authorities. The existing system was in dire need of revision. A mathematical model was developed to help the health authorities to keep their national medicines budget under control.

Multicentre observational trial

posted on September 01st 2009 by Ludwig Everaert
In support of the revision of the reimbursement criteria of a product reimbursed in Class I, we designed and launched a retrospective multicentre observational trial.

Class I reimbursement

posted on November 30th 2008 by Inneke Van de Vijver
Class I reimbursement was granted to Octreoscan in Belgium. Octreoscan imaging agent is a unique molecular imaging agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.

Class I reimbursement

posted on May 19th 2008 by Inneke Van de Vijver
Class I reimbursement was granted to Hexvix (product with a proven phamaco-economical plus value).

Class I reimbursement

posted on April 21st 2007 by Inneke Van de Vijver
DaTSCAN has successfully passed its individual revision of Class I reimbursement.

Readability testing for Pack Inserts

posted on January 02nd 2007 by Ludwig Everaert
According to the “Circular 469” letter of the Belgian FA, Pack Inserts submitted or approved before 26 May 2006 also will have to comply within 5 years (national procedure). This means that, by May 2011, all products already authorised in Belgium must be tested.

Pages